University of California, Los Angeles
Los Angeles, CA, United States
Dr. Volkmann is the Director of the UCLA Scleroderma Center and the Founder and Co-Director of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease (CTD-ILD) Program. Board-certified in Internal Medicine and Rheumatology, she cares for patients with systemic sclerosis and CTD-ILD. She is an active clinical and translational researcher. Her research largely focuses on understanding the cause of systemic sclerosis, identifying clinical and biological factors that predict outcomes in patients with systemic sclerosis, and helping to discover new therapies for systemic sclerosis and interstitial lung disease. She strives to provide humanistic and compassionate care and seeks to empower her patients to improve their health through traditional, as well as holistic treatment modalities.
Meet the Panel: Case-Based Interstitial Lung Disease
Sunday, November 12, 2023
9:00 AM – 9:45 AM PT
Disclosure(s): Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Horizon: Grant/Research Support (Ongoing); Kadmon: Grant/Research Support (Ongoing); Prometheus: Grant/Research Support (Ongoing); Roche: Consultant (Ongoing)
Sunday, November 12, 2023
9:00 AM – 11:00 AM PT
Disclosure(s): Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Horizon: Grant/Research Support (Ongoing); Kadmon: Grant/Research Support (Ongoing); Prometheus: Grant/Research Support (Ongoing); Roche: Consultant (Ongoing)
Monday, November 13, 2023
9:00 AM – 11:00 AM PT
Disclosure(s): Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Horizon: Grant/Research Support (Ongoing); Kadmon: Grant/Research Support (Ongoing); Prometheus: Grant/Research Support (Ongoing); Roche: Consultant (Ongoing)
Monday, November 13, 2023
12:30 PM – 1:15 PM PT
Disclosure information not submitted.
Wednesday, November 15, 2023
1:00 PM – 3:00 PM PT
Disclosure(s): Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Horizon: Grant/Research Support (Ongoing); Kadmon: Grant/Research Support (Ongoing); Prometheus: Grant/Research Support (Ongoing); Roche: Consultant (Ongoing)